Tracey G. Simon
Brigham and Women's Hospital · 228 works · 8,338 citations · h-index 48
Top works
- Mortality in biopsy-confirmed nonalcoholic fatty liver disease: results from a nationwide cohort
- Non-alcoholic fatty liver disease and risk of fatal and non-fatal cardiovascular events: an updated systematic review and meta-analysis
- Association of Aspirin with Hepatocellular Carcinoma and Liver-Related Mortality
- Administrative Coding in Electronic Health Care Record‐Based Research of NAFLD: An Expert Panel Consensus Statement
- Massive Intravascular Hemolysis From Clostridium perfringens Septicemia
- Non-alcoholic fatty liver disease and incident major adverse cardiovascular events: results from a nationwide histology cohort
- Association Between Aspirin Use and Risk of Hepatocellular Carcinoma
- Artificial intelligence for the prevention and clinical management of hepatocellular carcinoma
- Atorvastatin and fluvastatin are associated with dose‐dependent reductions in cirrhosis and hepatocellular carcinoma, among patients with hepatitis C virus: Results from ERCHIVES
- Antibiotic use and the development of inflammatory bowel disease: a national case-control study in Sweden
- The short‐term incidence of hepatocellular carcinoma is not increased after hepatitis C treatment with direct‐acting antivirals: An ERCHIVES study
- Advanced fibrosis is associated with incident cardiovascular disease in patients with non‐alcoholic fatty liver disease
- Non-alcoholic fatty liver disease in children and young adults is associated with increased long-term mortality
- Cancer Risk in Patients With Biopsy‐Confirmed Nonalcoholic Fatty Liver Disease: A Population‐Based Cohort Study
- Lipophilic Statins and Risk for Hepatocellular Carcinoma and Death in Patients With Chronic Viral Hepatitis: Results From a Nationwide Swedish Population
- Association of Genetic Variation With Cirrhosis: A Multi-Trait Genome-Wide Association and Gene–Environment Interaction Study
- Daily Aspirin Use Associated With Reduced Risk For Fibrosis Progression In Patients With Nonalcoholic Fatty Liver Disease
- AGA Clinical Practice Guideline on the Prevention and Treatment of Hepatitis B Virus Reactivation in At-Risk Individuals
- The MELD-Plus: A generalizable prediction risk score in cirrhosis
- Statin use is associated with a reduced risk of fibrosis progression in chronic hepatitis C